Allogene Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Business Update

Go back to Allogene Therapeutics Reports First Quarter 2024 Financial ResultsĀ and Business Update
(NASDAQ: ALLO) Delayed: 2.12 +0.02 (0.95%)
Previous Close $2.10    52 Week High
Open $2.03    52 Week Low
Day High $2.17    P/E N/A 
Day Low $2.03    EPS
Volume 1,110,418